34 results
424B3
SHPH
Shuttle Pharmaceuticals Holdings Inc
22 Mar 24
Prospectus supplement
6:07am
statements include, but are not limited to, statements about:
the initiation, timing, progress and results of our research and development programs … for, and manufacture, our research and development, preclinical and clinical trial drug supplies;
our ability to attract and retain qualified key management
8-K
EX-10.1
9mk2or1e6j cxztcj
30 Oct 23
Shuttle Pharma Advances Prostate Cancer Predictive Biomarker Program Through Exclusive License Agreement
5:14pm
424B3
vh954
24 Aug 23
Prospectus supplement
2:00pm
NT 10-Q
nxhe75vqy28u
15 May 23
Notice of late quarterly filing
5:26pm
S-8
gmpqx977h8t
12 Dec 22
Registration of securities for employees
4:23pm
10-Q
s8nqe0
14 Nov 22
Quarterly report
5:21pm
DRS
d1bq6g
29 Sep 22
Draft registration statement
12:00am
8-K
EX-10.1
wteutilmhlehbkgodkz
19 Sep 22
Entry into a Material Definitive Agreement
10:55am
424B4
xqsjhvg82e9b7
31 Aug 22
Prospectus supplement with pricing info
6:16am
UPLOAD
ktp6aqjthx5m66cf
31 Aug 22
Letter from SEC
12:00am